AbCellera Biologics Inc. ABCL
10.47 USD -0.55 (-4.99%)
Regular-session close
10.30 -0.17 -1.62%
After hours · Nov 19, 7:50 PM ET
10.38 Day range 11.29
2.75 52-week range 15.02
- YTD
- +206.14%
- 1 year
- +190.03%
ABCL revenue history
Revenue is income from the company’s ordinary business activities.
75,128,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 75,128,000 | 46,295,000 | 160.56% |
| FY 2024 | 2024-12-31 | 28,833,000 | -9,192,000 | -24.17% |
| FY 2023 | 2023-12-31 | 38,025,000 | -447,399,000 | -92.17% |
| FY 2022 | 2022-12-31 | 485,424,000 | 110,221,000 | 29.38% |
| FY 2021 | 2021-12-31 | 375,203,000 | 142,048,000 | 60.92% |
| FY 2020 | 2020-12-31 | 233,155,000 | 221,543,000 | 1907.88% |
| FY 2019 | 2019-12-31 | 11,612,000 | 2,781,000 | 31.49% |
| FY 2018 | 2018-12-31 | 8,831,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-11T07:00:37.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
